NHAU DZIKURU YECHUANGKUN BIOTECH MUMAKEKO WEKUMhiri kwemakungwa SHANGHAI CHUANGKUN BIOTECH TB/NTM NUCLEIC ACID DETECTION KIT(LYOPHILIZED) YAKABVISISHWA NEINDONESIA FDA!

Nguva pfupi yadarika, Shanghai Chuangkun Biotechnology Co., Ltd. yakawana chechipiri chekunyoresa cheIndonesia FDA cheTB/NTM Nucleic Acid yekuona kit(lyophilized), yakatsikwa ne (12+3) mhando yeHPV yekuona PCR kit mwedzi mumwe wapfuura.iyo yakazivisa kuti zvigadzirwa zveChuangkun Biotech zvakabvumidzwa neIndonesia FDA, kuvandudza zvigadzirwa zvakazvigadzira, uye nekupa rutsigiro rwakasimba kuChuangkun Biotech kuti iwedzere musika wepasi rose.

Sekureva kweWorld Health Organisation's Global TB Report 2022, vanhu vanosvika miriyoni gumi nemazana matanhatu vachabatwa neTB muna 2021. Kuwedzera ne4.5% kwaive kudarika gore ra2020. Zvichakadaro vanhu miriyoni imwe nemazana matanhatu vakafa nechirwere cherurindi gore rapfuura (kusanganisira 6.7% vaive pakati vanhu vanorarama neHIV).Nenzvimbo, nyaya zhinji dzeTB muna 2021 dzaive munzvimbo dzeWHO dzeSouth-East Asia (45%), Africa (23%) neWestern Pacific (18%), dziine zvikamu zvidiki muEastern Mediterranean (8.1%), Americas. (2.9%) uye Europe (2.2%).Tichifunga nezveCOVID-19 Pandemic, kudzivirira tibhii uye kudzora kuri kuramba kuchiwedzera kuomerwa neChirongwa cheKugumisa Tuberculosis yeWHO.

TB/NTM Nucleic Acid yekuona kit kubva kuCHUANGKUN Biotech inogadzirwa ne lyophilization maitiro .Iyo nzira ichagadzirisa kutadza kwekufambisa kwenguva refu kwechinyakare PCR yekuongorora kit, uye inounzawo kurongeka kwakanakisa uye mhedzisiro yemhando yepamusoro zvakanyanya pamusoro pekunaka kwekushandisa kwedu.

Shanghai Chuangkun Biotechnology Co., Ltd. yakawana chechipiri chekunyoresa chitupa cheIndonesia FDA cheTB/NTM Nucleic Acid yekuona kit, inoratidza kucherechedzwa neIndonesia FDA.Chuangkun Biotech ichave yakazvipira kuita chikamu munharaunda yekudzivirira tibhii uye kutonga nesimba.